Articles with public access mandates - Zeljko DebeljakLearn more
Not available anywhere: 1
Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity
N Drinković, M Beus, R Barbir, Ž Debeljak, BT Lovaković, N Kalčec, ...
Nanoscale 16 (19), 9412-9425, 2024
Mandates: European Commission
Available somewhere: 3
Who's in, who's out? Re‐evaluation of lipid raft residents
K Mlinac‐Jerkovic, K Ilic, M Zjalić, D Mandić, Ž Debeljak, M Balog, ...
Journal of neurochemistry 158 (3), 657-672, 2021
Mandates: US National Institutes of Health, European Molecular Biology Laboratory
Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues
Ž Debeljak, IV Vrček, N Drinković, V Micek, E Galić, D Gorup, M Ćurlin, ...
Analyst 147 (14), 3201-3208, 2022
Mandates: European Commission
Sex-related response of mice to silver nanoparticles after sub-acute exposure
L Božičević, R Barbir, W Goessler, V Micek, Ž Debeljak, I Pavičić, M Ćurlin, ...
10th International Conference on Nanotoxicology (NanoTox 2021), 181-182, 2021
Mandates: European Commission
Publication and funding information is determined automatically by a computer program